SEARCH

SEARCH BY CITATION

REFERENCES

  • Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215: 403410.
  • Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. 1999. Perlecan is essential for cartilage and cephalic development. Nat Genet 23: 354358.
  • Arikawa-Hirasawa E, Wilcox WR, Yamada Y. 2001. Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development. Am J Med Genet 106: 254257.
  • Arikawa-Hirasawa E, Le AH, Nishino I, Nonaka I, Ho NC, Francomano CA, Govindraj P, Hassell JR, Devaney JM, Spranger J, Stevenson RE, Iannaccone S, Dalakas MC, Yamada Y. 2002. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet 70: 13681375.
  • Chakravarti S, Horchar T, Jefferson B, Laurie GW, Hassell JR. 1995. Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence. J Biol Chem 270: 404409.
  • Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, Addicks K, Timpl R, Fassler R. 1999. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147: 11091122.
  • Ebens AJ, Garren H, Cheyette BN, Zipursky SL. 1993. The Drosophila anachronism locus: a glycoprotein secreted by glia inhibits neuroblast proliferation. Cell 74: 1527.
  • Eppig JT, Bult CJ, Kadin JA, Richardson JE, Blake JA, Anagnostopoulos A, Baldarelli RM, Baya M, Beal JS, Bello SM, Boddy WJ, Bradt DW, Burkart DL, Butler NE, Campbell J, Cassell MA, Corbani LE, Cousins SL, Dahmen DJ, Dene H, Diehl AD, Drabkin HJ, Frazer KS, Frost P, Glass LH, Goldsmith CW, Grant PL, Lennon-Pierce M, Lewis J, Lu I, Maltais LJ, McAndrews-Hill M, McClellan L, Miers DB, Miller LA, Ni L, Ormsby JE, Qi D, Reddy TB, Reed DJ, Richards-Smith B, Shaw DR, Sinclair R, Smith CL, Szauter P, Walker MB, Walton DO, Washburn LL, Witham IT, Zhu Y. 2005. The Mouse Genome Database (MGD): from genes to mice—a community resource for mouse biology. Nucleic Acids Res 33: D471D475.
  • Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. 2003. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31: 37843788.
  • Mackinnon AC, Qadota H, Norman KR, Moerman DG, Williams BD. 2002. C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol 12: 787797.
  • Maglott D, Ostell J, Pruitt KD, Tatusova T. 2005. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 33: D54D58.
  • McKusick VA. 1998. Mendelian Inheritance in Man. A Catalog of Human Genes and Genetic Disorders. Baltimore: Johns Hopkins University Press.
  • Merz DC, Alves G, Kawano T, Zheng H, Culotti JG. 2003. UNC-52/perlecan affects gonadal leader cell migrations in C. elegans hermaphrodites through alterations in growth factor signaling. Dev Biol 256: 173186.
  • Mongiat M, Otto J, Oldershaw R, Ferrer F, Sato JD, Iozzo RV. 2001. Fibroblast growth factor-binding protein is a novel partner for perlecan protein core. J Biol Chem 276: 1026310271.
  • Morita H, Yoshimura A, Inui K, Ideura T, Watanabe H, Wang L, Soininen R, Tryggvason K. 2005. Heparan sulfate of perlecan is involved in glomerular filtration. J Am Soc Nephrol 16: 17031710.
  • Mullen GP, Rogalski TM, Bush JA, Gorji PR, Moerman DG. 1999. Complex patterns of alternative splicing mediate the spatial and temporal distribution of perlecan/UNC-52 in Caenorhabditis elegans. Mol Biol Cell 10: 32053221.
  • Nicole S, Davoine CS, Topaloglu H, Cattolico L, Barral D, Beighton P, Hamida CB, Hammouda H, Cruaud C, White PS, Samson D, Urtizberea JA, Lehmann-Horn F, Weissenbach J, Hentati F, Fontaine B. 2000. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 26: 480483.
  • Park Y, Rangel C, Reynolds MM, Caldwell MC, Johns M, Nayak M, Welsh CJ, McDermott S, Datta S. 2003. Drosophila perlecan modulates FGF and hedgehog signals to activate neural stem cell division. Dev Biol 253: 247257.
  • Rodgers KD, Sasaki T, Aszodi A, Jacenko O. 2007. Reduced perlecan in mice results in chondrodysplasia resembling Schwartz-Jampel syndrome. Hum Mol Genet 16: 515528.
  • Rossi M, Morita H, Sormunen R, Airenne S, Kreivi M, Wang L, Fukai N, Olsen BR, Tryggvason K, Soininen R. 2003. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. Embo J 22: 236245.
  • Sharma B, Handler M, Eichstetter I, Whitelock JM, Nugent MA, Iozzo RV. 1998. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J Clin Invest 102: 15991608.
  • Sprague J, Bayraktaroglu L, Clements D, Conlin T, Fashena D, Frazer K, Haendel M, Howe DG, Mani P, Ramachandran S, Schaper K, Segerdell E, Song P, Sprunger B, Taylor S, Van Slyke CE, Westerfield M. 2006. The Zebrafish Information Network: the zebrafish model organism database. Nucleic Acids Res 34: D581585.
  • Stum M, Davoine CS, Vicart S, Guillot-Noel L, Topaloglu H, Carod-Artal FJ, Kayserili H, Hentati F, Merlini L, Urtizberea JA, Hammouda el H, Quan PC, Fontaine B, Nicole S. 2006. Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome. Hum Mutat 27: 10821091.
  • Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 46734680.
  • Tominaga M, Kurihara H, Honda S, Amakawa G, Sakai T, Tomooka Y. 2006. Molecular characterization of mitocalcin, a novel mitochondrial Ca2+-binding protein with EF-hand and coiled-coil domains. J Neurochem 96: 292304.
  • Voigt A, Pflanz R, Schafer U, Jackle H. 2002. Perlecan participates in proliferation activation of quiescent Drosophila neuroblasts. Dev Dyn 224: 403412.